Authors

1. Luo , Zebing
2. Xu , Wanzhu
3. Guo , Zhijun
4. Xu , Manjia
5. Lv , Xinxian
6. Chen , Chujun

Abstract

Among breast cancer patients with a TIVAP, 32.3% had asymptomatic thrombosis and 3.3% had symptomatic thrombosis. Clinical staff should pay close attention to these indicators and identify high-risk patients with TIVAP-related thrombosis as early as possible.